107 related articles for article (PubMed ID: 19227240)
1. [Proliferation and death of liver mononuclear cells in immune lesions induced by concanavalin A and anti-liver antibodies in mice].
Makohon NV; Pavlovych SI; Bryzhina TM; Aleksiuk LI; Sukhina VS; Hrushka NH; Aleksieieva IM
Fiziol Zh (1994); 2008; 54(6):49-57. PubMed ID: 19227240
[TBL] [Abstract][Full Text] [Related]
2. [Functional activity of peritonal macrophages in liver immune damage of cellular and antibody genesis in mice].
Martynova TV; Aleksieieva IM
Fiziol Zh (1994); 2009; 55(1):36-42. PubMed ID: 19441713
[TBL] [Abstract][Full Text] [Related]
3. Dietary fish oil exacerbates concanavalin A induced hepatitis through promoting hepatocyte apoptosis and altering immune cell populations.
Xia S; Han M; Li X; Cheng L; Qiang Y; Wu S; Zhang M; Xu H; Liu X; Shao Q
J Toxicol Sci; 2014 Apr; 39(2):179-90. PubMed ID: 24646698
[TBL] [Abstract][Full Text] [Related]
4. Metformin aggravates immune-mediated liver injury in mice.
Volarevic V; Misirkic M; Vucicevic L; Paunovic V; Simovic Markovic B; Stojanovic M; Milovanovic M; Jakovljevic V; Micic D; Arsenijevic N; Trajkovic V; Lukic ML
Arch Toxicol; 2015 Mar; 89(3):437-50. PubMed ID: 24770553
[TBL] [Abstract][Full Text] [Related]
5. [Characteristic of readiness of thymocytes and peripheral blood lymphocytes to proliferation and apoptosis in experimental chronic liver disease].
Briukhin GV; Barysheva SV; Nikolina OV
Morfologiia; 2004; 126(6):43-5. PubMed ID: 15839251
[TBL] [Abstract][Full Text] [Related]
6. Specific antibodies induced by DNA vaccination with extracellular domain of CD25 gene protect against ConA-induced autoimmune hepatitis.
Xu L; Zhang F; Xu W; Xiong S
Clin Immunol; 2009 Sep; 132(3):412-9. PubMed ID: 19501551
[TBL] [Abstract][Full Text] [Related]
7. Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein.
Nicoletti F; Zaccone P; Xiang M; Magro G; Di Mauro M; Di Marco R; Garotta G; Meroni P
Cytokine; 2000 Apr; 12(4):315-23. PubMed ID: 10805211
[TBL] [Abstract][Full Text] [Related]
8. A murder mystery in the liver: who done it and how?
Dara L; Liu ZX; Kaplowitz N
J Clin Invest; 2016 Nov; 126(11):4068-4071. PubMed ID: 27760053
[TBL] [Abstract][Full Text] [Related]
9. Tolerance induction in response to liver inflammation.
Erhardt A; Tiegs G
Dig Dis; 2010; 28(1):86-92. PubMed ID: 20460895
[TBL] [Abstract][Full Text] [Related]
10. A novel accessory role of neutrophils in concanavalin A-induced hepatitis.
Hatada S; Ohta T; Shiratsuchi Y; Hatano M; Kobayashi Y
Cell Immunol; 2005 Jan; 233(1):23-9. PubMed ID: 15893298
[TBL] [Abstract][Full Text] [Related]
11. Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes.
Margalit M; Abu Gazala S; Alper R; Elinav E; Klein A; Doviner V; Sherman Y; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G917-25. PubMed ID: 15976388
[TBL] [Abstract][Full Text] [Related]
12. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis.
Kremer M; Hines IN; Milton RJ; Wheeler MD
Hepatology; 2006 Jul; 44(1):216-27. PubMed ID: 16799967
[TBL] [Abstract][Full Text] [Related]
13. N-acetylglucosaminyltransferase V exacerbates concanavalin A-induced hepatitis in mice.
Kamada Y; Sato M; Kida S; Akita M; Mizutani K; Fujii H; Sobajima T; Yoshida Y; Shinzaki S; Takamatsu S; Takehara T; Miyoshi E
Mol Med Rep; 2015 May; 11(5):3573-84. PubMed ID: 25572342
[TBL] [Abstract][Full Text] [Related]
14. Tr1 regulatory T cells induced by ConA pretreatment prevent mice from ConA-induced hepatitis.
Ye F; Yan S; Xu L; Jiang Z; Liu N; Xiong S; Wang Y; Chu Y
Immunol Lett; 2009 Feb; 122(2):198-207. PubMed ID: 19200442
[TBL] [Abstract][Full Text] [Related]
15. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
Wang J; Sun R; Wei H; Dong Z; Tian Z
Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
[TBL] [Abstract][Full Text] [Related]
16. Immune mechanisms of Concanavalin A model of autoimmune hepatitis.
Wang HX; Liu M; Weng SY; Li JJ; Xie C; He HL; Guan W; Yuan YS; Gao J
World J Gastroenterol; 2012 Jan; 18(2):119-25. PubMed ID: 22253517
[TBL] [Abstract][Full Text] [Related]
17. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice.
Erhardt A; Biburger M; Papadopoulos T; Tiegs G
Hepatology; 2007 Feb; 45(2):475-85. PubMed ID: 17256743
[TBL] [Abstract][Full Text] [Related]
18. Amphiregulin alleviated concanavalin A-induced acute liver injury
Wu Q; Chen J; Hu X; Zhu Y; Xie S; Wu C; Pei Z; Xiong S; Peng Y
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):473-483. PubMed ID: 32806961
[TBL] [Abstract][Full Text] [Related]
19. RNA interference targeting Fas protects mice from fulminant hepatitis.
Song E; Lee SK; Wang J; Ince N; Ouyang N; Min J; Chen J; Shankar P; Lieberman J
Nat Med; 2003 Mar; 9(3):347-51. PubMed ID: 12579197
[TBL] [Abstract][Full Text] [Related]
20. Salecan protected against concanavalin A-induced acute liver injury by modulating T cell immune responses and NMR-based metabolic profiles.
Sun Q; Xu X; Yang X; Weng D; Wang J; Zhang J
Toxicol Appl Pharmacol; 2017 Feb; 317():63-72. PubMed ID: 28109817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
